Literature DB >> 14656562

Auditory lexical-semantic processing impairments in aphasic patients reflected in event-related potentials (N400).

Tomoyuki Kojima1, Kimitaka Kaga.   

Abstract

OBJECTIVE: Event-related potentials (ERPs) and response latencies were recorded from aphasic subjects with auditory language processing impairments and age-matched normal controls, while performing a lexical-semantic evaluation task, aiming at clarifying whether ERPs could be a reliable measure for indicating language impairments in aphasic patients.
METHODS: The stimuli were 50 pairs of spoken words (prime word-target word): 25 pairs, which were semantically and/or associatively related to each other, and 25 pairs which were not. The subjects pressed a switch in response to the presentation of target words semantically related to the prime words. The ERP component analyzed in this study was N400.
RESULTS: With the performances, the response latencies were longer in the aphasic subjects than in the normal controls. With the ERPs, onset latencies of N400 were shifted behind in the aphasic patients compared to the normal controls. For the aphasic patients, there were correlations between the size of N400 and performances in auditory comprehension evaluated in the aphasia test.
CONCLUSION: The conclusions drawn from the results are that not only response latencies in the lexical-semantic judgement task, but also N400 effects, may be a reliable clinical measure of the severity of even mild lexical-semantic impairments in aphasic patients.

Entities:  

Mesh:

Year:  2003        PMID: 14656562     DOI: 10.1016/j.anl.2003.07.007

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  1 in total

1.  Sentence Context Prevails Over Word Association in Aphasia Patients with Spared Comprehension: Evidence from N400 Event-Related Potential.

Authors:  Elvira Khachatryan; Miet De Letter; Gertie Vanhoof; Ann Goeleven; Marc M Van Hulle
Journal:  Front Hum Neurosci       Date:  2017-01-10       Impact factor: 3.169

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.